Search

History

Vision & Values

Science Focus

Corporate Profile

Sustainable Development

Purchasing & Suppliers

Purchasing at Boehringer Ingelheim

Our Responsibility

Human Health Our Responsibility

Heart Diseases

Lung Diseases

Boehringer Ingelheim | Boehringer Ingelheim ANZ

Boehringer Ingelheim is one of the world’s leading family-owned pharmaceutical companies, developing medicines to address unmet needs in human and animal health.

We strengthen Australia’s biosecurity

Boehringer awarded contract for FMD antigen bank

Keith's Journey with Heart of Australia

Rural and remote medical needs in Australia

Expertise in Emergency and Exotic Animal Diseases

Empowering independence with Guide Dogs

Youth programs shape future farmers for success

Livestock producers in New Zealand are facing challenges that make it hard for the next generation to succeed as farmers. Rising costs, production pressures, and changes in industry practices are causing difficulties. However, a group of young farmers cal

Empowering People, Making a Difference

VTI Day is a special event in Boehringer Ingelheim's cultural calendar

Code of Conduct

Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live.

Boehringer Ingelheim recognised as Top Employer for 2024

Boehringer Ingelheim Recognised as Top Employer for 2024, Demonstrating Strong Commitment to People Development in Australia and New Zealand

He’s my dog, I’m his human

Getting a Guide Dog was a life-changing moment for Lucy, who lost her sight in a car accident as a teenager.

Drug Discovery at Boehringer Ingelheim

Find out more about the drug discovery process at Boehringer Ingelheim

The Angels Initiative Surpasses 1,000 Registrations for Acute Stroke Training

Global program equips HCPs for optimal acute stroke treatment

About Us

Human Health

Animal Health

Partnering